Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02556177 · ClinicalTrials.gov registry record · NA
Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2
A NA study, sponsored by GE Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 477
- Enrollment target
NCT02556177: Completed NA study, sponsored by GE Healthcare.
NCT02556177 is a NA study that has completed, run by GE Healthcare. The registered enrollment target is 477 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02556177, a NA study, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 477 participants
- Enrollment target
Study Summary
This is an open-label, non-randomized, prospective, multi-site, parallel group (segment), hypothesis-generating study designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical neuropsychological assessments and GE Research Pack II advanced MR imaging in mTBI patients. The results are primarily intended for scientific inquiry and engineering development purposes, and may be used in future regulatory submissions.
Primary Outcome
MRI image data sets collected from subjects who completed the study.
Interventions
- PROCEDURE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-01-31 |
| Phase | NA |
What the finished NCT02556177 record still lists
NCT02556177 is an interventional study that assigns participants to a tested intervention. The registered 477 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT02556177 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02556177 about?
NCT02556177 is a clinical study titled "Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2". This is an open-label, non-randomized, prospective, multi-site, parallel group (segment), hypothesis-generating study designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical neuropsychological assessments and GE Research Pack II advanc...
What is the current status of trial NCT02556177?
This trial is currently completed. It is a NA study. The enrollment target is 477 participants. The study started on 2015-11. Estimated completion is 2018-01-31.
What interventions are being tested in trial NCT02556177?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02556177?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02556177's enrollment target sits among peer trials
477 219th of 2000 higher than 1,781 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03911700 · 477 participants · NA
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
- NCT06997497 · 477 participants · Phase 3
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- NCT05446272 · 478 participants · NA
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
- NCT06172296 · 478 participants · Phase 3
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia